u.s. fda issues warning letter to sun pharma, questions manufacturing practices at halol facility
Published 1 year ago • 449 plays • Length 2:36Download video MP4
Download video MP3
Similar videos
-
2:16
sun pharma's halol facility receives u.s. fda warning letter | business lunch | cnbc-tv18
-
0:47
#shorts | sun pharma shares tank after us fda issues 10 observations to its halol facility
-
3:56
sun pharma news: u.s. fda lists company's halol plant under an import alert | halftime report
-
3:03
sun pharma dadra unit: us fda warning letter shows multiple repeat observations | n18v | cnbc tv18
-
3:06
sun pharma receives warning letter from us fda for its halol plant
-
2:47
sun pharma halol plant | us fda issues 3 observations in form 483 | cnbc tv18
-
1:00
us fda on sun pharma’s dadra unit: failed to clean, maintain, sanitise equipment at apt intervals
-
23:34
sun pharma in focus | us fda to re-inspect halol unit | movers & shakers | cnbc tv18
-
2:29
us fda finds incomplete lab records for sun pharma's dadra unit
-
1:54
sun pharma slips in trade after receiving a warning letter from the us fda for its dadra facility
-
2:20
boost for sun pharma | u.s.fda nod for 1st product from halol | cnbc tv18
-
1:55
sun pharma mohali unit: u.s. fda flags compliance concerns | halftime report | cnbc-tv18
-
1:32
us fda finds incomplete lab records for sun pharma's dadra unit
-
3:06
sun pharma under pressure: u.s. fda issues letter for the firm's mohali facility | trading hour
-
23:49
us fda issues 6 observation on sun pharma | halftime report | cnbc-tv18
-
3:21
torrent pharma's gujarat facility gets u.s fda observation, lupin's tarapur unit gets warning letter
-
5:10
vishal manchanda on impact of u.s fda oai status on sun pharma | bazaar open exchange | cnbc-tv18
-
1:18
us fda records 11 observations for sun pharma’s dadra facility
-
11:40
sun pharma: us fda's bitter pill. catch all the details on markets today